Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Enzymes Market Evolve in Terms of Growth and Size by 2029?

Over recent years, the enzymes market has seen rapid expansion in its size. The projections suggest a growth from $13.38 billion in 2024 to $15.2 billion in 2025, marking a compound annual growth rate (CAGR) of 13.6%. The thriving growth observed in the past is credited to factors such as widened globalization and market development, investments in research and development, amplified consumer awareness and demand, advancements in bioprocessing technology, and focus on waste minimization and recycling.

The market for enzymes is forecasted to witness a swift expansion in the coming years, with its size projected to reach “$25.34 billion by 2029, growing at a compound annual growth rate (CAGR) of 13.6%.” The anticipated growth during the forecast period is ascribable to factors such as market demand dynamics, emphasis on environmentally friendly practices, trends in health and nutrition, development in biofuel and renewable energy, as well as emerging applications. Some significant trends expected to influence the market during the forecast period include advancements in biotechnology, increased demand for sustainability, the food and beverage industry’s demand, industrial applications’ expansion, and consumers’ preference for organic products.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3425&type=smp

What factors are expected to fuel Enzymes market growth in the coming years?

The enzyme market is poised for growth, fueled by the increasing occurrence of digestive disorders. These disorders affect the digestive system and include conditions such as gastroesophageal reflux disease (GERD), cancer, irritable bowel syndrome (IBS), lactose intolerance, hiatal hernia, and gallstones. Digestive enzymes aid in transforming food into smaller molecules for easier absorption by the body. The National Center for Biotechnology Information (NCBI), a United States-based resource for scientific research, reported in October 2022 that irritable bowel syndrome (IBS) affects between 10% to 15% of the U.S. population. Around 12% of these patients seek medical attention in primary care settings for IBS-related concerns. This increasing prevalence of digestive disorders is hence, propelling the growth of the enzyme market.

The enzymes market covered in this report is segmented –

1) By Product Type: Asparaginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Other Products

2) By Application: Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease, Other Applications

3) By End User: Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories

Subsegments:

1) By Asparaginase: L-asparaginase, Erwinia Asparaginase, Pegylated Asparaginase

2) By Lipase: Gastric Lipase, Pancreatic Lipase, Fungal Lipase, Bacterial Lipase

3) By Protease: Serine Proteases, Cysteine Proteases, Aspartic Proteases, Metalloproteases

4) By Nattokinase: Nattokinase Powder, Nattokinase Capsules

5) By Chitinase: Plant Chitinase, Microbial Chitinase

6) By Serratiopeptidase: Serratiopeptidase Tablets, Serratiopeptidase Capsules

7) By Collagenase: Type I Collagenase, Type II Collagenase, Type III Collagenase

8) By Ligase: DNA Ligase, RNA Ligase

9) By Other Products: Amylase, Cellulase, Beta-Glucanase, Other Specialty Enzymes

What Long-Term Trends Are Likely To Affect The Enzymes Market?

Key players in the enzyme market, such as Chiesi Global Rare Diseases, are creating trailblazing products like Lamzede to enhance patient care. Lamzede, or velmanase alfa, is a treatment for alpha-mannosidosis, a rare genetic disorder linked to a shortage of the lysosomal alpha-galactosidase-A enzyme. In May 2023, the US Food and Drug Administration gave its approval to the US pharmaceutical manufacturer, Chiesi Global Rare Diseases, to produce Lamzede for non-neurological symptoms in patients suffering from mild-to-moderate alpha-mannosidosis. Developed in mammalian Chinese hamster ovary (CHO) cells through recombinant DNA technology, Lamzede is a recombinant version of human alpha-mannosidase. It also stands as the premiere enzyme replacement therapy greenlit in the United States for treating non-central nervous system symptoms of alpha-mannosidosis.

What Are The Most Active Companies In The Enzymes Market Today?

Major companies operating in the enzymes market include Novozymes A/S, DuPont Industrial Biosciences, BASF SE, Koninklijke DSM N.V., Chr. Hansen Holding A/S, Roche Holding AG, Advanced Enzyme Technologies Ltd., AB Enzymes GmbH, Codexis Inc., Dyadic International Inc., Amano Enzyme Inc., Adisseo France SAS, Biocatalysts Ltd., Amano Enzyme Inc., Enzyme Development Corporation, Creative Enzymes, Hayashibara Co. Ltd., Thermo Fisher Scientific Inc., Associated British Foods Plc, Lonza Group AG, Novus International Inc., Epygen Biotech, DSM Nutritional Products AG, Soufflet Biotechnologies SAS, Beijing Leili Marine Bioindustry Inc., Jiangsu Boli Bioproducts Co. Ltd.

https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

Which Regional Markets Are Attracting The Most Investment In Enzymes?

North America was the largest region in the enzymes market in 2024. The regions covered in the enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3425&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model